DOCSLIB.ORG

Alveolar Macrophages Intermediate Between Blood Monocytes And

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Alveolar Macrophages Intermediate Between Blood Monocytes And Lung Macrophages Serve as Obligatory Intermediate between Blood Monocytes and Alveolar Macrophages This information is current as Limor Landsman and Steffen Jung of September 28, 2021. J Immunol 2007; 179:3488-3494; ; doi: 10.4049/jimmunol.179.6.3488 http://www.jimmunol.org/content/179/6/3488 Downloaded from References This article cites 49 articles, 18 of which you can access for free at: http://www.jimmunol.org/content/179/6/3488.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 28, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Lung Macrophages Serve as Obligatory Intermediate between Blood Monocytes and Alveolar Macrophages1 Limor Landsman and Steffen Jung2 Alveolar macrophages are a unique type of mononuclear phagocytes that populate the external surface of the lung cavity. Early studies have suggested that alveolar macrophages originate from tissue-resident, local precursors, whereas others reported their derivation from blood-borne cells. However, the role of circulating monocytes as precursors of alveolar macrophages was never directly tested. In this study, we show through the combined use of conditional cell ablation and adoptive cell transfer that alveolar macrophages originate in vivo from blood monocytes. Interestingly, this process requires an obligate intermediate stage, the differentiation of blood monocytes into parenchymal lung macrophages, which subsequently migrate into the alveolar space. We also provide direct evidence for the ability of both lung and alveolar macrophages to proliferate. The Journal of Immunology, 2007, 179: 3488–3494. Downloaded from he constant exposure to environmental microbial chal- from the BM (21). As for the origin of alveolar M⌽, although they lenges renders the respiratory tract one of the major sites clearly belong to the hemopoietic lineage, a direct connection to T of primary viral and bacterial infections (1). Highlighting monocytic precursors remains to be shown (22). Moreover, several this state of permanent alert, the lung, which comprises paren- studies published during the 1970s and 1980s reported either cir- chyma and alveolar space, is seeded with numerous mononuclear culating or local precursor for alveolar M⌽, depending on the http://www.jimmunol.org/ phagocytes, including dendritic cells (DC)3 and macrophages method used (for review, see Ref. 22). Based on kinetic studies, (M⌽) (1, 2). In steady state, M⌽ are the major cell type in the Bowden and Adamson (23) suggested, for instance, a dual origin alveolar space, representing ϳ90% of its hematopoietic cellular of alveolar M⌽: from blood-borne precursor and from proliferat- content (1) and playing a key role in its clearance from pulmonary ing cells in the lung parenchyma. With the discovery of alveolar pathogens and dying cells (3). Pulmonary M⌽, however, are poor DC (24), it became, however, unclear whether this study referred T cell stimulators (4, 5), and have even been shown to suppress to two distinct cell types, i.e., alveolar DC and M⌽. In addition, lung inflammations, probably by inhibiting DC function (4, 6–10). the alveolar M⌽ population was reported to remain unaffected by Alveolar M⌽ are bone marrow (BM)-derived cells (11, 12). depletion of blood monocytes (25), leading to the conclusion that Interestingly, however, after whole body irradiation and engraft- alveolar M⌽ are not monocyte derived (26). Because alveolar M⌽ by guest on September 28, 2021 ment, their replacement by donor BM cells takes considerably are eventually replaced by BM-derived cells (11), the existence of longer than that of most other cells of the hematopoietic system circulating precursor was, however, not ruled out. Taken together, (13, 14). Depending on the irradiation protocol used, the time re- the identity of the alveolar M⌽ precursor, as well as its own origin, quired for the complete exchange of alveolar M⌽ has been re- remains to be revealed (22). ported to vary from several weeks up to 1 year (11, 13–16). This Through an adoptive monocyte transfer approach, we recently delay in alveolar M⌽ replacement by BM-derived cells is dis- showed that parenchymal lung M⌽ originate in vivo from blood cussed as one of the critical causes for the sensitivity of BM trans- monocytes (27). Furthermore, we reported that only one of the two low high Ϫ plantation patients to pulmonary infections (17, 18). major murine monocyte subsets, the Gr1 CX3CR1 CCR2 Monocytes are BM-derived circulating phagocytes that are con- cells (28), harbors the immediate potential to give rise to paren- sidered to be the in vivo M⌽ precursors (19, 20). However, spe- chymal lung M⌽ (27). In this study, we extended these studies and cific M⌽ populations, such as the brain microglia, have been investigated the in vivo origin of alveolar M⌽ using a combination shown to originate from local precursors, without persisting input of conditional cell ablation and reconstitution. We show that grafted blood monocytes can give rise to alveolar M⌽. However, we provide evidence that alveolar M⌽ do not originate directly Department of Immunology, Weizmann Institute of Science, Rehovot, Israel from blood monocytes, but require a parenchymal lung M⌽ inter- Received for publication April 17, 2007. Accepted for publication July 3, 2007. mediate. Lastly, we directly show that both lung and alveolar M⌽ The costs of publication of this article were defrayed in part by the payment of page can undergo proliferation. charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 This study was supported by the MINERVA Foundation. S.J. is the incumbent of the Pauline Recanati Career Development Chair and a scholar of the Benoziyo Center for Materials and Methods Molecular Medicine. Mice 2 Address correspondence and reprint requests to Dr. Steffen Jung, Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel. E-mail address: This study involved the use of the following C57BL/6 mouse strains: [email protected] CD11c:diphtheria toxin (DTx) receptor (DTR) transgenic mice (B6.FVB- 3 Tg(Itgax-DTR/GFP)57Lan/J) that carry a DTR transgene under the murine Abbreviations used in this paper: DC, dendritic cell; BAL, bronchoalveolar lavage; GFP cd11c promotor (29); CX3CR1 mice harboring a targeted replacement BM, bone marrow; DTR, diphtheria toxin receptor; DTx, diphtheria toxin; int, inter- ␮ mediate; i.t., intratracheal; M⌽, macrophage; PCNA, proliferating cell nuclear Ag; of the cx3cr1 gene by a GFP reporter (30); and MT mice (C57BL/6-IgH- wt, wild type. 6tmlCgn) lacking the membrane exon of the Ig ␮-chain gene, and therefore are B cell deficient (31). Mice were backcrossed with CD45.1 mice Copyright © 2007 by The American Association of Immunologists, Inc. 0022-1767/07/$2.00 (B6.SJL-Ptprca Pep3b/BoyJ) when indicated. All mice were maintained www.jimmunol.org The Journal of Immunology 3489 under specific pathogen-free conditions and handled under protocols ap- proved by the Weizmann Institute Animal Care Committee, according to international guidelines. Cell isolations Mice were sacrificed, and blood was collected from main artery and sub- jected to a Ficoll density gradient (Amersham) to remove erythrocytes and neutrophils. For bronchoalveolar lavage (BAL), the trachea was exposed to allow insertion of a catheter, through which the lung was filled and washed four times with 1 ml of PBS without Ca2ϩ/Mg2ϩ. Lung parenchyma was then collected and digested with 4 mg/ml collagenase D (Roche) for1hat 37°C, followed by incubation with ACK buffer to lyse erythrocytes. All isolated cells were suspended in PBS supplemented with 2 mM EDTA, 0.05% sodium azide, and 1% FCS. Flow cytometric analysis The following fluorochrome-labeled mAbs were purchased from eBio- science and used according to manufacturer’s protocols: PE-conjugated anti-CD11c and anti-CD115 Abs, allophycocyanin-conjugated streptavidin and anti-CD11b Ab, and biotin-conjugated anti-CD45.1, CD11c, CD115, and MHC II Abs. PerCP-conjugated anti-CD11b Ab was purchased from BD Pharmingen. PE-labeled anti-proliferating cell nuclear Ag (PCNA) Ab Downloaded from was purchased from DakoCytomation and used according to the manufac- turer’s protocol for S phase-specific staining, with modifications. Before staining with the anti-PCNA Ab, cells were incubated with indicated bi- otin-conjugated Abs, followed by methanol fixation. Fixed cells were then incubated with streptavidin-fluorochrome conjugates and stained for PCNA. Cells were analyzed on a FACSCalibur cytometer (BD Bio- sciences) using CellQuest software (BD Biosciences). http://www.jimmunol.org/ ⌽ Cell transfers FIGURE 1. In vivo depletion and reconstitution of pulmonary M . Flow cytometric analysis of collagenase-digested lung and BAL fluid of For blood monocyte transfers, ϳ20 mice were sacrificed and bled to collect CD11c:DTR mice. A, Depletion of lung and alveolar M⌽ of CD11c:DTR an average of 18 ml of blood. Erythrocytes and neutrophils were removed mice upon DTx treatment. On day 0, mice were treated i.t. with either PBS by a Ficoll density gradient, and cells were washed and exposed to biotin- or DTx (100 ng) or left untreated. BAL and lung cells were isolated on day conjugated anti-CD115 Ab (eBioscience), followed by incubation with 1 and stained with PE-coupled anti-CD11c Ab and allophycocyanin-cou- strepavidin-conjugated MACS beads (Miltenyi Biotec).
Load more

Recommended publications
  • Severe COVID-19: Understanding the Role of Immunity, Endothelium, and Coagulation in Clinical Practice
    ARTIGO DE REVISÃO ISSN 1677-7301 (Online) COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica Severe COVID-19: understanding the role of immunity, endothelium, and coagulation in clinical practice Simone Cristina Soares Brandão1 , Emmanuelle Tenório Albuquerque Madruga Godoi1 , Júlia de Oliveira Xavier Ramos1 , Leila Maria Magalhães Pessoa de Melo2 , Emanuel Sávio Cavalcanti Sarinho1 Resumo O SARS-CoV-2 é o responsável pela pandemia da COVID-19. O sistema imunológico é fator determinante no combate à infecção viral e, quando atua equilibrada e eficientemente, a doença é autolimitada e benigna. Uma parcela significativa da população, porém, apresenta resposta imune exacerbada. Os indivíduos diabéticos, hipertensos, obesos e com doenças cardiovasculares, infectados pelo vírus, apresentam maior chance de progredir para formas graves. Essas doenças estão relacionadas a processos inflamatórios crônicos e disfunção endotelial. Os receptores do tipo Toll estão presentes nas células de defesa e participam da imunopatologia de doenças cardiovasculares e metabólicas, levando à produção de citocinas pró-inflamatórias quando ativados. Devido à ação viral e à hiperativação do sistema imune, estados de hiperinflamação, hiperativação plaquetária, disfunção endotelial e hipercoagulabilidade são desenvolvidos, predispondo a tromboses venosas e arteriais. Discutiremos sobre a interação entre a COVID-19, a imunidade, o endotélio e a coagulação, como também sobre as possíveis causas de doenças cardiometabólicas impactarem negativamente na evolução da COVID-19. Palavras-chave: COVID-19; endotélio; imunidade; aterosclerose; trombose. Abstract SARS-CoV-2 is responsible for the COVID-19 pandemic. The immune system is a determinant factor in defense against viral infections. Thus, when it acts in a balanced and effective manner the disease is self-limited and benign.
    [Show full text]
  • Regulation of Macrophage Development and Function in Peripheral Tissues
    REVIEWS Regulation of macrophage development and function in peripheral tissues Yonit Lavin, Arthur Mortha, Adeeb Rahman and Miriam Merad Abstract | Macrophages are immune cells of haematopoietic origin that provide crucial innate immune defence and have tissue-specific functions in the regulation and maintenance of organ homeostasis. Recent studies of macrophage ontogeny, as well as transcriptional and epigenetic identity, have started to reveal the decisive role of the tissue stroma in the regulation of macrophage function. These findings suggest that most macrophages seed the tissues during embryonic development and functionally specialize in response to cytokines and metabolites that are released by the stroma and drive the expression of unique transcription factors. In this Review, we discuss how recent insights into macrophage ontogeny and macrophage–stroma interactions contribute to our understanding of the crosstalk that shapes macrophage function and the maintenance of organ integrity. Mononuclear phagocyte Macrophages are key components of the innate immune characterized the transcriptional and epigenetic pro- system system that reside in tissues, where they function as grammes of tissue-resident macrophages and revealed (MPS). A group of bone immune sentinels. They are uniquely equipped to sense the extent of diversity in these populations1,8. In addi- marrow-derived cells and respond to tissue invasion by infectious microorgan- tion to differences in ontogeny, locally derived tissue (monocytes, macrophages and isms and tissue
    [Show full text]
  • Screening Chest X-Ray Interpretations and Radiographic Techniques IOM GUIDELINES FIRST EDITION Iii
    FIRST EDITION 2015 Screening Chest X-Ray Interpretations and Radiographic Techniques IOM GUIDELINES Global Radiology Coordination and Teleradiology Centre Migration Health Division International Organization for Migration (Manila Administrative Centre) 24th floor Citibank Tower, Paseo De Roxas 8741, Makati city 1226 Metro Manila, Philippines Email: [email protected] • [email protected] Tel: +632 230 1674 The opinions expressed in the report are those of the authors and do not necessarily reflect the views of the International Organization for Migration (IOM). The designations employed and the presentation of material throughout the report do not imply the expression of any opinion whatsoever on the part of IOM concerning the legal status of any country, territory, city or area, or of its authorities, or concerning its frontiers or boundaries. IOM is committed to the principle that humane and orderly migration benefits migrants and society. As an intergovernmental organization, IOM acts with its partners in the international community to: assist in meeting the operational challenges of migration; advance understanding of migration issues; encourage social and economic development through migration; and uphold the human dignity and well-being of migrants. Author Sifrash Meseret GELAW, MD Radiologist, MPH; Global Radiology Coordinator IOM, Manila Administrative Centre, Manila, Philippines Major Contributor Anthony MACDERMOTT, MD former Global HAP Quality Coordinator, IOM, Regional Office for Asia and the Pacific, Bangkok, Thailand Additional
    [Show full text]
  • The Systemic Inflammation of Alveolar Hypoxia Is Initiated by Alveolar
    The Systemic Inflammation of Alveolar Hypoxia Is Initiated by Alveolar Macrophage–Borne Mediator(s) Jie Chao1, John G. Wood1, Victor Gustavo Blanco1, and Norberto C. Gonzalez1 1Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas Alveolar hypoxia produces widespread systemic inflammation in rats. The inflammation appears to be triggered by activation of mast CLINICAL RELEVANCE cells by a mediator released from alveolar macrophages, not by the reduced systemic partial pressure of oxygen (PO2). If this is correct, This study demonstrates a direct link, via a circulating the following should apply: (1) neither mast cells nor tissue macro- mediator, between activation of alveolar macrophages by phages should be directly activated by hypoxia; and (2) mast cells low alveolar PO2, and degranulation of systemic mast cells, should be activated when in contact with hypoxic alveolar macro- the first step in the systemic inflammatory cascade. A phages, but not with hypoxic tissue macrophages. We sought here to candidate mediator, monocyte chemoattractant protein-1, determine whether hypoxia activates isolated alveolar macro- was identified. Roles of low tissue PO2 and activation of phages, peritoneal macrophages, and peritoneal mast cells, and to tissue macrophages were ruled out. The phenomenon study the response of the microcirculation to supernatants of these described could participate in the inflammation underlying cultures. Rat mesenteric microcirculation intravital microscopy was the systemic effects seen in conditions associated with low combined with primary cultures of alveolar macrophages, peritoneal alveolar PO2. macrophages, and peritoneal mast cells. Supernatant of hypoxic alveolar macrophages, but not of hypoxic peritoneal macrophages, produced inflammation in mesentery.
    [Show full text]
  • When a Wedge Resection Is Indicated for a Pulmonary Aspergilloma? About 12 Cases
    ISSN: 2574-1241 Volume 5- Issue 4: 2018 DOI: 10.26717/BJSTR.2018.09.001837 H Harmouchi Hicham. Biomed J Sci & Tech Res Research Article Open Access When a wedge resection is indicated for a pulmonary aspergilloma? About 12 cases M Lakranbi1,2, H Harmouchi*1, L Belliraj1, FZ Ammor1, I Issoufou1, Y Ouadnouni1,2 and M Smahi1,2 1Department of Thoracic Surgery, CHU Hassan II of Fez, Morocco 2Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdallah University, Morocco Received: : September 26, 2018; Published: : October 05, 2018 *Corresponding author: H Harmouchi Hicham, Thoracic surgery department, CHU Hassan II of Fez-Morocco Abstract Introduction: Pulmonary aspergilloma is the colonization by a fungus of the genus Aspergillus fumigatus in a pulmonary cavity most often preexisting of tuberculous origin. Surgery is the basic treatment with anatomical lung resection. However, wedge resection is possible especially in simple aspergilloma. The purpose of this study is to report the indications to perform wedge resection and compare it to the literature review. Material and Methods: This is a retrospective study, done within our department of thoracic surgery over a period of 8 years, collecting all the patients who had a pulmonary aspergilloma, and whose intervention was a wedge resection. Result: It was 11 men and one woman, with an average age of 44.5 years. The history of pulmonary tuberculosis was found in 7 patients (58.3%). Hemoptysis was present in all patients (100%). The radiological assessment showed right-sided involvement in 7 patients (58.3%), and on the left in 5 patients (41.6%), with an image excavated in 5 patients (41.6%).
    [Show full text]
  • Intrathoracic Meningocele Associated with Neurofibromatosis Type 1 and a Novel Technique for Surgical Repair: Case Report
    CASE REPORT J Neurosurg Spine 27:291–294, 2017 Intrathoracic meningocele associated with neurofibromatosis Type 1 and a novel technique for surgical repair: case report Paramita Das, MD, Tarini Goyal, MD, and Matthew A. Hunt, MD Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota Neurofibromatosis Type 1 (NF1) is a neurocutaneous disorder that can have associated spinal abnormalities related to both bone and dural dysplasia. Thoracic meningoceles are one spine anomaly associated with NF1, although they are a fairly uncommon pathology. Surgical techniques to treat these meningoceles, usually undertaken only when the patient is symptomatic, are targeted at decreasing the size of the protrusion and improving lung capacity. Surgical interventions discussed in the literature include shunting the pseudomeningocele, primary repair with laminectomy, thoracoscopic plication, and reinforcement of the closure with cement, muscle, or fascia. Authors here report the case of a 43-year- old woman with NF1 with worsening pulmonary function tests and in whom shunting of the pseudomeningocele failed. Subsequently, a posterolateral thoracotomy was performed. The dura mater was reconstructed and primarily closed. On this closure a Gore-Tex soft-tissue patch was placed along with polypropylene mesh and Evicel fibrin sealant, followed by titanium mesh. At the end of the procedure, a chest tube was left in place and therapeutic pneumoperitoneum was performed to decrease the dead space as the lung did not fully expand with positive-pressure ventilation. The patient’s pulmonary function tests improved after the procedure. Thoracic meningoceles are uncommon and difficult pathologies to treat surgically. Although shunting is arguably the least invasive surgical option, it can fail in some patients.
    [Show full text]
  • Infectious Pneumonia in the Immunocompetent Host: What the Radiologist Should Know
    Published online: 2021-07-27 THORACIC IMAGING Infectious pneumonia in the immunocompetent host: What the radiologist should know Rohini G Ghasi, Sunil K Bajaj Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India Correspondence: Dr. Rohini G Ghasi, Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi ‑ 110 029, India. E‑mail: [email protected] Abstract Lung infections are an important cause of morbidity and mortality, particularly because of the rising antimicrobial resistance. According to the clinical setting, they can be categorized as community‑acquired pneumonia and hospital‑acquired pneumonia. Radiological patterns of lung infections are lobar consolidation, bronchopneumonia, interstitial pattern, and nodular pattern. In addition, typical imaging features of several infections serve as “red flag signs” in reaching a diagnosis or altering the management. It would be prudent for the radiologist to be well informed regarding these aspects of lung infections to be able to make a valuable contribution to the management. Key words: Imaging; immunocompetent; lung infections; pneumonia; radiological signs Introduction incidence of organ transplants, and emergence of newer viruses with atypical imaging features. Radiologists need The most common question put up to an Indian radiologist to be more aware about the dominant imaging patterns in in the setting of pulmonary infection is “does it look different types of these infections and the “red flag” imaging tubercular?” Once tuberculosis is ruled out, most of our signs which make a difference to the management. job is considered done. We need to, however, contribute more to the diagnostic trail. Lung infections caused by Clinical Setting organisms other than Mycobacterium tuberculosis, are, nevertheless, a major cause of morbidity and mortality.
    [Show full text]
  • Regulation of Antigen-Presenting Cell Function(S) in Lung and Airway Tissues
    Eur Respir J 1993, 6, 120-129 REVIEW Regulation of antigen-presenting cell function(s) in lung and airway tissues P.G. Holt Regulation of antigen-presenting cell function(s) in lung and airway tissues. Correspondence: P.G. Holt P.G. Holt. Division of Cell Biology ABSTRACT: A variety of cell populations present in respiratory tract tissues The Western Australian Research can express the function-associated molecules on their surface which are re­ Institute for Child Health quired for presentation of antigen to T-lymphocyte receptors. However, the GPO Box 0184 Perth, Western Australia 6001. potential role of individual cell populations in regulation of local T -lymphocyte· dependent immune reactions in the lung and airways depends on a variety of Keywords: Antigen presentation additional factors, including their precise localisation, migration characteris­ airway epithelium tics, expression ofT-cell "eo-stimulatory" signals, responsiveness to inflamma­ class li MHC (I a) antigen expression tory (in particular cytokine) stimuli, host immune status, and the nature of the T-lymphocyte activation antigen challenge. Recent evidence (reviewed below) suggests that tJ1e induc­ tion of primary immunity (viz. "sensitisation") to inhaled antigens is normally Received: April 30, 1992 controlled by specialised populations of Dendritic Cells, which perform a sur­ Accepted: September 8, 1992 veillance role within the epithelia of the upper and lower respiratory tract; in the pre-sensitised host, a variety of other cell populations (both bone-marrow derived and mesenchymal) may participate in re-stimulation of "memory" T­ lymphocytes. Eur Respir J .. 1993, 6, 120-129. Aberrant immunoinflammatory responses to exog­ control of T-cell activation is normally operative to enous antigens are important aetiological factors in a protect the lung against unnecessary and/or exagger­ large proportion of the common non-malignant respi­ ated responses to foreign antigens.
    [Show full text]
  • View Open Access Alveolar Hypoxia, Alveolar Macrophages, and Systemic Inflammation Jie Chao, John G Wood and Norberto C Gonzalez*
    Respiratory Research BioMed Central Review Open Access Alveolar hypoxia, alveolar macrophages, and systemic inflammation Jie Chao, John G Wood and Norberto C Gonzalez* Address: Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA Email: Jie Chao - [email protected]; John G Wood - [email protected]; Norberto C Gonzalez* - [email protected] * Corresponding author Published: 22 June 2009 Received: 2 April 2009 Accepted: 22 June 2009 Respiratory Research 2009, 10:54 doi:10.1186/1465-9921-10-54 This article is available from: http://respiratory-research.com/content/10/1/54 © 2009 Chao et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Diseases featuring abnormally low alveolar PO2 are frequently accompanied by systemic effects. The common presence of an underlying inflammatory component suggests that inflammation may contribute to the pathogenesis of the systemic effects of alveolar hypoxia. While the role of alveolar macrophages in the immune and defense functions of the lung has been long known, recent evidence indicates that activation of alveolar macrophages causes inflammatory disturbances in the systemic microcirculation. The purpose of this review is to describe observations in experimental animals showing that alveolar macrophages initiate a systemic inflammatory response to alveolar hypoxia. Evidence obtained in intact animals and in primary cell cultures indicate that alveolar macrophages activated by hypoxia release a mediator(s) into the circulation.
    [Show full text]
  • 25Th International Symposium on Infections in the Critically Ill Patient
    medical sciences Meeting Report 25thMeeting InternationalReport Symposium on Infections in the Critically25th International Ill Patient Symposium on Infections in the Critically Ill Patient Antonio Artigas 1,*, Jean Carlet 2,*, Ricard Ferrer 3,*, Michael Niederman 4,* and AntoniAntonio Torres Artigas5,* 1,*, Jean Carlet 2,*, Ricard Ferrer 3,*, Michael Niederman 4,* and Antoni Torres 5,* 1 1 CriticalCritical Care Care Center, Sabadell Hospital, University Institute Parc TaulTaulí,í, AutonomousAutonomous UniversityUniversity ofof Barcelona, Barcelona,08193 Ciberes, Ciberes, Spain Spain 2 2 PresidentPresident of of the the World World Alliance Alliance against against Anti Antibioticbiotic Resistance Resistance (WAAAR), (WAAAR), Paris, 75008 France Paris, France 3 3 IntestiveIntestive Care Care Medicine Medicine Department, Department, Vall Vall d’Hebron d’Hebron University University Hospital. Hospital, Barcelona, 08035 Barcelona, Spain Spain 4 4 DivisionDivision of of Pulmonary Pulmonary and and Critical Critical care Care Medicine, Medicine, New New York York Presbyterian Presbyterian Hospital, Hospital, Weill Weill Cornell Cornell Medical Medical College,College, USA New York, NY 10065, USA 5 5 PulmonologyPulmonology Department, Department, Clinic Clinic Hospital, Hospital, Universi Universityty of of Barcelona, Barcelona, Barcel CIBERona, Enfermedades CIBER Enfermedades Respiratorias, Respiratorias,08036 Barcelona, Spain Spain * * Correspondence:Correspondence: [email protected] [email protected] (A.A.); (A.A.); jeancarl [email protected]@gmail.com (J.C.); (J.C.); [email protected] [email protected] (R.F.); (R.F.); [email protected]@current-science.com (M.N.); (M.N.); [email protected] [email protected] (A.T.) (A.T.) Received: 10 February 2020; Accepted: 12 February 2020; Published: 13 February 2020 Received: 12 February 2020; Accepted: 12 February 2020; Published: 13 February 2020 1.1.
    [Show full text]
  • Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps
    biomolecules Review Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps Brandon Bautista-Becerril 1,2,†, Rebeca Campi-Caballero 2,3,†, Samuel Sevilla-Fuentes 4, Laura M. Hernández-Regino 5, Alejandro Hanono 6 , Al Flores-Bustamante 7, Julieta González-Flores 2 , Carlos A. García-Ávila 5 , Arnoldo Aquino-Gálvez 8 , Manuel Castillejos-López 9 , Armida Juárez-Cisneros 1 and Angel Camarena 1,* 1 Laboratorio HLA, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico; [email protected] (B.B.-B.); [email protected] (A.J.-C.) 2 Programa MEDICI, Carrera Médico Cirujano, FES Iztacala, Universidad Nacional Autónoma de México, Mexico City 54090, Mexico; [email protected] (R.C.-C.); [email protected] (J.G.-F.) 3 Laboratorio de Neuropsicofarmacología, Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico 4 Departamento de Infectología, Hospital General de México Eduardo Liceaga, Mexico City 06720, Mexico; [email protected] 5 Escuela Nacional de Ciencias Biológicas, Programa de Posgrado, Instituto Politécnico Nacional, Mexico City 11340, Mexico; [email protected] (L.M.H.-R.); [email protected] (C.A.G.-Á.) Citation: Bautista-Becerril, B.; 6 Facultad de Ciencias de la Salud, Universidad Anáhuac México Norte, Mexico City 52786, Mexico; Campi-Caballero, R.; Sevilla-Fuentes, [email protected] S.; Hernández-Regino, L.M.; Hanono, 7 Laboratorio de Farmacología, Instituto
    [Show full text]
  • A Novel Anatomical Lung Phantom and Its Applications in Lung Perfusion Scans for Pulmonary Embolism Diagnosis Norlaili Ahmad Kabir University of Wollongong
    University of Wollongong Research Online University of Wollongong Thesis Collection University of Wollongong Thesis Collections 2012 A novel anatomical lung phantom and its applications in lung perfusion scans for pulmonary embolism diagnosis Norlaili Ahmad Kabir University of Wollongong Recommended Citation Kabir, Norlaili Ahmad, A novel anatomical lung phantom and its applications in lung perfusion scans for pulmonary embolism diagnosis, Doctor of Philosophy thesis, Faculty of Engineering, University of Wollongong, 2012. http://ro.uow.edu.au/theses/3659 Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library: [email protected] A NOVEL ANATOMICAL LUNG PHANTOM AND ITS APPLICATIONS IN LUNG PERFUSION SCANS FOR PULMONARY EMBOLISM DIAGNOSIS A thesis submitted in fulfilment of the requirements for the award of the degree DOCTOR OF PHILOSOPHY from UNIVERSITY OF WOLLONGONG by NORLAILI AHMAD KABIR, BSc (Hons), MSc CENTRE FOR MEDICAL RADIATION PHYSICS, ENGINEERING PHYSICS, FACULTY OF ENGINEERING (2012) 2 Thesis Certification I, Norlaili Ahmad Kabir, declare that this thesis, submitted in partial fulfilment of the requirements for the award of Doctor of Philosophy, in the Centre for Medical Radiation Physics, University of Wollongong, is wholly my own work unless otherwise referenced or acknowledged. The document has not been submitted for qualifications at any other academic institutions. Norlaili A. Kabir 31 st March 2012 3 Contents Thesis Certification
    [Show full text]